Immunology - Aneknowledge.com

Dual ACE2 epitope-based biomimetic receptors for selective sensing of SARS-CoV variants.

Smart Biosensors: Dual ACE2 Epitope Receptors Offer Rapid Detection of SARS-CoV Variants

A new study reveals how dual ACE2 epitope-based biomimetic receptors deliver rapid, highly selective detection of SARS-CoV variants, offering a next-gen solution for evolving pandemics.

Aneknowledge October 2, 2025

Phage receptor binding protein and Fc fragment fusion enhances phagocytosis of Y. enterocolitica

Bioinformatics Emerging Science Genetic Engineering

Phage-Protein Fusion Boosts Immune Defense Against Yersinia enterocolitica Infections

A new study shows that fusing phage receptor binding proteins with Fc fragments enhances immune cell recognition and phagocytosis of Yersinia enterocolitica, offering a novel antibacterial strategy.

Aneknowledge September 29, 2025

Ligilactobacillus salivarius alleviated intestinal damage induced by Salmonella in mice via regulating microbiota.

Agriculture Emerging Science Food Technology

Probiotic Power: Ligilactobacillus salivarius Shows Promise in Fighting Salmonella-Induced Gut Damage

A new study reveals how Ligilactobacillus salivarius, a probiotic bacterium, reduces intestinal damage, restores gut microbiota balance, and fights Salmonella infections in mice.

Aneknowledge September 27, 2025

Epstein-Barr virus nuclear antigen 1 upregulates Derlin1 and PSMD10 expression in HeLa cells

Emerging Science Genetics Health

Epstein-Barr Virus Protein EBNA1 Found to Boost Cancer-Linked Genes in HeLa Cells

New research shows Epstein-Barr virus EBNA1 protein upregulates Derlin1 and PSMD10 in HeLa cells, revealing potential cancer progression pathways.

Aneknowledge September 22, 2025

Imidazole propionate is a driver and therapeutic target in atherosclerosis

Biochemistry Emerging Science Immunology

Gut Microbe Molecule Emerges as a Hidden Driver of Atherosclerosis

New research identifies imidazole propionate (ImP), a gut microbe–derived metabolite, as a driver of atherosclerosis. Blocking its pathway offers a promising therapeutic target for heart disease prevention.

Aneknowledge September 16, 2025

Emerging Science Immunology

Tumor-Derived Nanozymes Open New Frontiers in Targeted Cancer Therapy

Researchers engineered tumor-derived covalent organic framework (COF) nanozymes that combine chemotherapy and photothermal therapy for precise, effective cancer treatment.

Aneknowledge September 12, 2025

Emerging Science Genetic Engineering Immunology

New Antibody-Based Approach Enables Safer Stem Cell Transplantation for Fanconi Anemia

A phase 1b trial shows that an anti-CD117 antibody (briquilimab) enables stem cell transplantation without toxic irradiation or busulfan in children with Fanconi anemia.

Aneknowledge September 5, 2025

Emerging Science Genetic Engineering Immunology

Bacteria Engineered to Glycosylate Full-Length IgG: A Breakthrough in Antibody Production

A newly discovered single-subunit enzyme enables E. coli to glycosylate full-length IgG antibodies, paving the way for cost-effective biopharmaceutical production.

Aneknowledge September 1, 2025

A new fluorescent STING ligand sensor enables rapid screening of cancer immunotherapy boosters

Emerging Science Immunology

Lighting Up the Immune System: A Fluorescent Sensor to Boost Cancer Immunotherapy

Discover how a new fluorescent STING ligand sensor enables rapid screening of cancer immunotherapy boosters. A leap forward in precision oncology and immune activation.

Aneknowledge July 26, 2025

Bamboo sharks is now being used as a small animal model for producing single-domain antibodies (sdAbs), also known as nanobodies.

Immunology

Bamboo Shark: The Surprising New Model for Single-Domain Antibody Research

Discover how the bamboo shark is emerging as a powerful small-animal model for producing single-domain antibodies—redefining the future of immunotherapy and diagnostics.

Aneknowledge July 24, 2025